Search Results - Xiaolong Yu
- Showing 1 - 4 results of 4
-
1
Multi‐Mode Triboelectric Nanogenerator for Football Impact Monitoring and Mechanical Energy Harvesting by Xi Chen, Xiaolong Yu
Published 2025-07-01Abstract The integration of digital products and sensors significantly enhances motion monitoring accuracy, addressing the limitations of hawk‐eye technology. Triboelectric nanogenerators (TENGs) provide innovative, low‐cost solutions for developing intelligent digital motion monitoring systems. In...
Get full text
Article -
2
Converting Waste into Treasure: Efficient Adsorption of Cr(VI) Using Iron-Modified Rice Straw Biochar by Hang Liu, Runlin Yao, Mingling Yu, Zongda Ye, Yingrui Lu, Xiaolong Yu, Jin Tang, Jianteng Sun
Published 2025-05-01Hexavalent chromium (Cr(VI)) is of significant interest in the environmental field due to its high toxicity. Biochar is commonly used as an adsorbent for Cr(VI) removal from wastewater. However, its lower removal efficiency remains a persistent challenge. This study develops an iron-modified rice st...
Get full text
Article -
3
An Efficient Flicker-Free FEC Coding Scheme for Dimmable Visible Light Communication Based on Polar Codes by Junbin Fang, Zhen Che, Zoe Lin Jiang, Xiaolong Yu, Siu-Ming Yiu, Kui Ren, Xiaoqing Tan, Zhe Chen
Published 2017-01-01Visible light communication (VLC) can provide short-range optical wireless communication, together with illumination using light-emitting diode (LED) lightings. Since conventional forward error correction (FEC) codes cannot provide two lighting related features, dimming support, and flicker mitigati...
Get full text
Article -
4
Population Pharmacokinetics and Model-Informed Precision Dosing of Clobazam Based on the Developmental and Genetic Characteristics of Children with Epilepsy by Yali Tuo, Xiaolong Yu, Sichan Li, Jun Wang, Maochang Liu, Xinwen Song, Jiehui Ma, Yang Wang, Zhisheng Liu, Dan Sun
Published 2025-06-01<b>Background/Objectives:</b> This study aimed to characterize the pharmacokinetic profiles of clobazam (CLB) and its active metabolite, N-desmethylclobazam (N-CLB), by establishing a population pharmacokinetic (PPK) model in Chinese children with epilepsy to propose individualized dosin...
Get full text
Article